DLTR
Dollar Tree, Inc
Featured
CytomX Therapeutics, Inc. (CTMX) Reports Net Loss for FY25
Q4 2025 loss at CytomX Therapeutics, Inc. (CTMX) widened to $0.20 per share GAAP, worse than the -$0.09 estimate (116.4% wider).
17 minutes ago
Dollar Tree, Inc Earnings Call Transcript
Dollar Tree, Inc (NASDAQ: DLTR) Q4 2025 Earnings Call dated Mar. 16, 2026 Corporate Participants: Daniel Delrosario — Investor Relations...
Latest Transcripts
LiveMarket News
View All
U.S. Regulators Turn Up the Heat on Big Tech Acquisitions
For years, Silicon Valley relied on acquisitions as a core growth strategy. Large tech companies frequently bought startups to expand...
Costco’s Earnings Reignite the Consumer Resilience Debate
TL;DR: Costco’s latest earnings beat expectations, reinforcing the narrative that the U.S. consumer is still spending but the market is...
Airlines Face Margin Squeeze as Oil Spike Hits Fuel Costs
TL;DR: U.S. airlines abandoned fuel hedging years ago and with oil surging, that decision is suddenly coming back to haunt...